PharmacyCodes



Chlormezanonum [INN-Latin] en es it fr

Chlormezanonum [INN-Latin] Brand names, Chlormezanonum [INN-Latin] Analogs

Chlormezanonum [INN-Latin] Brand Names Mixture

  • No information avaliable

Chlormezanonum [INN-Latin] Chemical_Formula

C11H12ClNO3S

Chlormezanonum [INN-Latin] RX_link

No information avaliable

Chlormezanonum [INN-Latin] fda sheet

Chlormezanonum [INN-Latin] msds (material safety sheet)

Chlormezanonum [INN-Latin] Synthesis Reference

No information avaliable

Chlormezanonum [INN-Latin] Molecular Weight

273.737 g/mol

Chlormezanonum [INN-Latin] Melting Point

116.2 oC

Chlormezanonum [INN-Latin] H2O Solubility

2500 mg/L (hardly soluble)

Chlormezanonum [INN-Latin] State

Solid

Chlormezanonum [INN-Latin] LogP

1.208

Chlormezanonum [INN-Latin] Dosage Forms

No information avaliable

Chlormezanonum [INN-Latin] Indication

Used in the management of anxiety and in the treatment of muscle spasm.

Chlormezanonum [INN-Latin] Pharmacology

Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).

Chlormezanonum [INN-Latin] Absorption

No information avaliable

Chlormezanonum [INN-Latin] side effects and Toxicity

Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.

Chlormezanonum [INN-Latin] Patient Information

No information avaliable

Chlormezanonum [INN-Latin] Organisms Affected

Humans and other mammals